Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
OXANTEL (AS OXANTEL EMBONATE), PYRANTEL (EQUIVALENT TO PYRANTEL EMBONATE PH.EUR.), PRAZIQUANTEL
Vetoquinol UK Limited
QP52AA51
OXANTEL (AS OXANTEL EMBONATE), PYRANTEL (EQUIVALENT TO PYRANTEL EMBONATE PH.EUR.), PRAZIQUANTEL
Tablets
POM: Prescription Only Medicine as defined in relevant national legislation
Canine
praziquantel, combinations
Endoparasiticide
Authorised
2008-01-25
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Dolpac Tablets for Large Dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Tablet. Pale yellow to yellow, oblong tablet with breaking line. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematode and cestode species: Nematodes: _Toxocara canis,_ _Toxascaris leonina,_ _Ancylostoma caninum,_ _Uncinaria stenocephala,_ _Trichuris vulpis._ Cestodes: _Dipylidium caninum_, _Taenia spp._ _Echinococcus multilocularis_ _Echinococcus granulosus_ 4.3 CONTRAINDICATIONS See section 4.8. Each tablet contains: ACTIVE SUBSTANCES: Oxantel 500.70 mg (equivalent to 1397.5 mg of oxantel embonate) Pyrantel 124.85 mg (equivalent to 360 mg of pyrantel embonate) Praziquantel 125 mg Excipient to one 2375 mg divisible tablet EXCIPIENTS: For a full list of excipients, see section 6.1. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _0_ _5_ _/_ _0_ _1_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _5_ _2_ _6_ _8_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class. Fleas serve as intermediate hosts for one of the common tapeworms –_ Dipylidium caninum_. Tapeworm infes Pročitajte cijeli dokument